Dual-mode untargeted metabolomic analysis reveals compound diversity in ready-to-drink beverages, suggesting varying health potentials.
Background: The rapid expansion of functional ready-to-drink (RTD) beverages—formulated with prebiotic fibers, botanical extracts, and reduced sugar—has outpaced systematic characterization of their small-molecule composition. Methods: We applied dual-mode untargeted high-resolution liquid chromatography–tandem mass spectrometry (LC–MS/MS), integrating hydrophilic interaction (HILIC) and reversed-phase C18 separations, to profile five commercial RTD beverages spanning distinct formulation categories: Coca-Cola®, Poppi® Orange, OLIPOP® Cream Soda, Pure Leaf® Unsweetened Black Tea, and BeePop™ Peach + Orange Blossom Honey. Results: Across all products, 478 compounds were structurally annotated at Metabolomics Standards Initiative (MSI) Levels 1 and 2, of which 42 matched compounds with reported bioactivity in a curated literature-based reference database. Seventeen compounds—including the NAD+ precursor trigonelline and multiple B vitamins—were detected across all five products. The number and diversity of compounds with reported bioactivity varied substantially by product and correlated with botanical ingredient complexity. Conclusions: This work presents a qualitative molecular survey of the RTD beverage category using standardized, dual-mode untargeted metabolomics, providing a reference dataset for future targeted quantitation studies.
No takes yet. Share an insight, caveat, or question.
Blaženović et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: